Matches in Wikidata for { <http://www.wikidata.org/entity/Q80427546> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q80427546 description "article scientifique publié en 2007" @default.
- Q80427546 description "artículu científicu espublizáu en febreru de 2007" @default.
- Q80427546 description "im Februar 2007 veröffentlichter wissenschaftlicher Artikel" @default.
- Q80427546 description "scientific article published on 09 February 2007" @default.
- Q80427546 description "wetenschappelijk artikel" @default.
- Q80427546 description "наукова стаття, опублікована в лютому 2007" @default.
- Q80427546 name "Are ex vivo neutralising antibodies against IFN-beta always detrimental to therapeutic efficacy in multiple sclerosis?" @default.
- Q80427546 name "Are ex vivo neutralising antibodies against IFN-beta always detrimental to therapeutic efficacy in multiple sclerosis?" @default.
- Q80427546 type Item @default.
- Q80427546 label "Are ex vivo neutralising antibodies against IFN-beta always detrimental to therapeutic efficacy in multiple sclerosis?" @default.
- Q80427546 label "Are ex vivo neutralising antibodies against IFN-beta always detrimental to therapeutic efficacy in multiple sclerosis?" @default.
- Q80427546 prefLabel "Are ex vivo neutralising antibodies against IFN-beta always detrimental to therapeutic efficacy in multiple sclerosis?" @default.
- Q80427546 prefLabel "Are ex vivo neutralising antibodies against IFN-beta always detrimental to therapeutic efficacy in multiple sclerosis?" @default.
- Q80427546 P1433 Q80427546-484CFB83-DA29-4455-8715-FAF3B763CA30 @default.
- Q80427546 P1476 Q80427546-FF1FD596-6AF6-4E5E-8F4A-1A1903EE7446 @default.
- Q80427546 P2093 Q80427546-1D58E5A3-0EE3-4000-B4AF-0C9DD0FEEAEB @default.
- Q80427546 P2093 Q80427546-A280420F-6779-4792-8E23-9F815EAA1D43 @default.
- Q80427546 P304 Q80427546-F748FBD0-695C-4823-B27F-43A07549BD15 @default.
- Q80427546 P31 Q80427546-3CDE1061-AAC1-436A-9522-9BC0E8C8EABA @default.
- Q80427546 P356 Q80427546-A252D70A-978F-4659-A2DA-AECA79E94D1F @default.
- Q80427546 P433 Q80427546-37EE12AC-B7C6-4357-9830-5ECBBD420E7A @default.
- Q80427546 P478 Q80427546-86DB56ED-69A3-4E41-A9A0-6DAC39F4EC03 @default.
- Q80427546 P50 Q80427546-37AEA0E1-1E6F-4645-A488-57BA35EF89AA @default.
- Q80427546 P577 Q80427546-497C5423-D9A6-442E-92F0-F2A17BF12FF3 @default.
- Q80427546 P698 Q80427546-C9F52C28-5A2D-426C-82EE-4AD92EFF5C02 @default.
- Q80427546 P356 1352458506072344 @default.
- Q80427546 P698 17548440 @default.
- Q80427546 P1433 Q1952449 @default.
- Q80427546 P1476 "Are ex vivo neutralising antibodies against IFN-beta always detrimental to therapeutic efficacy in multiple sclerosis?" @default.
- Q80427546 P2093 "Bendtzen K" @default.
- Q80427546 P2093 "Koch-Henriksen N" @default.
- Q80427546 P304 "616-621" @default.
- Q80427546 P31 Q13442814 @default.
- Q80427546 P356 "10.1177/1352458506072344" @default.
- Q80427546 P433 "5" @default.
- Q80427546 P478 "13" @default.
- Q80427546 P50 Q12331359 @default.
- Q80427546 P577 "2007-02-09T00:00:00Z" @default.
- Q80427546 P698 "17548440" @default.